2026-04-14T04:21:29Zhttps://recercat.cat/oai/request
oai:recercat.cat:20.500.12327/14242025-10-22T11:18:25Zcom_2072_4428com_2072_4427col_2072_487898
RECERCAT author EFSA Panel on Animal Health and Welfare (AHAW) author Nielsen, Søren Saxmose author Alvarez, Julio author Bicout, Dominique Joseph author Calistri, Paolo author Canali, Elisabetta author Drewe, Julian Ashley author Garin-Bastuji, Bruno author Gonzales Rojas, José Luis author Gortázar Schmidt, Christian author Herskin, Mette author Michel, Virginie author Miranda Chueca, Miguel Ángel author Padalino, Barbara author Pasquali, Paolo author Sihvonen, Liisa Helena author Spoolder, Hans author Ståhl, Karl author Velarde, Antonio author Viltrop, Arvo author Winckler, Christoph author Gubbins, Simon author Stegeman, Jan Arend author Antoniou, Sotiria-Eleni author Aznar, Inma author Broglia, Alessandro author Lima, Eliana author Van der Stede, Yves author Zancanaro, Gabriele author Roberts, Helen Clare other Producció Animal group Benestar Animal 2025-10-22T11:18:25Z 2025-10-22T11:18:25Z 2021-07-21 Nielsen, Søren Saxmose, Julio Alvarez, Dominique Joseph Bicout, Paolo Calistri, Elisabetta Canali, Julian Ashley Drewe, and Bruno Garin‐Bastuji et al. 2021. "Assessment Of The Control Measures Of The Category A Diseases Of Animal Health Law: Classical Swine Fever". EFSA Journal 19 (7). doi:10.2903/j.efsa.2021.6707. 1831-4732 http://hdl.handle.net/20.500.12327/1424 https://doi.org/10.2903/j.efsa.2021.6707 EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases (‘Animal Health Law’). This opinion belongs to a series of opinions where these control measures will be assessed, with this opinion covering the assessment of control measures for Classical swine fever (CSF). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period and (iii) the minimum radii of the protection and surveillance zones, and the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, details of the model used for answering these questions are presented in this opinion as well as the transmission kernels used for the assessment of the minimum radius of the protection and surveillance zones. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. Here, several recommendations are given on how to increase the effectiveness of some of the sampling procedures. Based on the average length of the period between virus introduction and the reporting of a CSF suspicion, the monitoring period was assessed as non-effective. In a similar way, it was recommended that the length of the measures in the protection and surveillance zones were increased from 15 to 25 days in the protection zone and from 30 to 40 days in the surveillance zone. Finally, the analysis of existing Kernels for CSF suggested that the radius of the protection and the surveillance zones comprise 99% of the infections from an affected establishment if transmission occurred. Recommendations provided for each of the scenarios assessed aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to CSF. eng Attribution-NoDerivatives 4.0 International Assessment of the control measures of the category A diseases of Animal Health Law: Classical Swine Fever info:eu-repo/semantics/article